{"resourceType":"ValueSet","id":"response-to-neoadjuvant-therapy","meta":{"lastUpdated":"2015-06-11T16:01:03.224+10:00","profile":["http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>ResponseToNeoadjuvantTherapy</h2><div><p>The response of the tumour to neoadjuvant treatment must be recorded.</p>\n</div><p><b>Copyright Statement:</b> This value set includes content from SNOMED CT, which is copyright Â© 2002+ International         Health Terminology Standards Development Organisation (IHTSDO), and distributed by         agreement    between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this         agreement</p><p>This value set includes codes from the following code systems:</p><ul><li>Include all codes defined in <a href=\"http://build.fhir.org/codesystem-snomedct.html\">http://snomed.info/sct</a></li><li>Include all codes defined in <a href=\"CodeSystem-response-to-neoadjuvant-therapy.html\">http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy</a></li></ul></div>"},"url":"http://fhir.hl7.org.au/fhir/rcpa/ValueSet/response-to-neoadjuvant-therapy","version":"20150625","name":"ResponseToNeoadjuvantTherapy","status":"draft","experimental":false,"publisher":"HL7 (FHIR Project)","contact":[{"telecom":[{"system":"other","value":"http://hl7.org/fhir"},{"system":"email","value":"fhir@lists.hl7.org"}]}],"date":"2015-06-11T16:01:03+10:00","description":"The response of the tumour to neoadjuvant treatment must be recorded.","copyright":"This value set includes content from SNOMED CT, which is copyright Â© 2002+ International         Health Terminology Standards Development Organisation (IHTSDO), and distributed by         agreement    between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this         agreement","compose":{"include":[{"system":"http://snomed.info/sct"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy"}]},"expansion":{"identifier":"urn:uuid:dd85e08b-8687-44f0-93a1-eb3ecef12f4d","timestamp":"2016-11-29T20:20:14+11:00","parameter":[{"name":"profile","valueUri":"http://hl7.org/fhir/ExpansionProfile/dc8fd4bc-091a-424a-8a3b-6198ef146891"},{"name":"expansion-profile","valueString":"http://hl7.org/fhir/ExpansionProfile/dc8fd4bc-091a-424a-8a3b-6198ef146891"},{"name":"limitedExpansion","valueBoolean":true},{"name":"version","valueUri":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy?version=20150625"}],"contains":[{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"not_applicable","display":"Not applicable"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"uncertain","display":"Uncertain if this is applicable"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"no_prior_treatment","display":"No prior treatment"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"grade_0","display":"Grade 0 (complete response) No viable cancer cells"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"grade_1","display":"Grade 1 (moderate response) Single cells or small groups of cancer cells"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"grade_2","display":"Grade 2 (minimal response) Residual cancer outgrown by fibrosis"},{"system":"http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy","code":"grade_3","display":"Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer"}]}}